Trial Profile
An open label, single cohort, randomized, 4-period crossover Phase 1 study to determine the effect of meal timing relative to CRN00808 administration on the safety and pharmacokinetics of CRN00808 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Paltusotine (Primary)
- Indications Acromegaly
- Focus Pharmacokinetics
- Sponsors Crinetics Pharmaceuticals
- 25 Feb 2019 Status changed from not yet recruiting to completed.
- 08 Oct 2018 New trial record